Navigation Links
Merck KGaA and Nano-Terra Announce Extension of Nanotechnology Solutions Alliance
Date:10/7/2008

Merck KGaA (EMD in North America) announced today the extension of its existing strategic alliance with Nano-Terra, Inc., a leading nanotechnology co-development company.

DARMSTADT, Germany (Business Wire EON) October 7, 2008 -- The original agreement between the companies, announced in February 2007, was to develop innovative, nanotechnology-based products and solutions based on Merck's materials.

After successfully meeting initial development milestones, this new agreement will focus on specific application development for Merck customers and moving the technical capabilities into the marketplace for commercialization.

Under the new agreement, which extends the partnership through 2011, Nano-Terra will develop novel application techniques for existing Merck materials which are designed to address market opportunities where smaller (micron and nanometer) feature sizes are required for certain printable electronics components. The Merck fabrication processes will be based on Nano-Terra's proprietary soft lithography technology, invented and pioneered by Professor George Whitesides of Harvard University, a co-founder of Nano-Terra, and the partners will share commercialization rights on a global basis. Terms of the agreement were not disclosed.

The new development work will be done at Nano-Terra's lab facilities in Cambridge, with close cooperation of a Merck scientific team and by EMD Chemicals, Merck's North American affiliate.

  • Thomas Geelhaar, Vice President Liquid Crystals R&D and Business Development Chemicals of Merck KGaA, said, "We were very pleased by the progress made in the initial stages of our relationship with Nano-Terra. We look forward to our continued collaboration with Professor Whitesides and his team, and to
    '/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
2. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
3. The African Medical and Research Foundation (AMREF) Honors Merck & Co., Inc. with Global Corporate Philanthropy Award
4. Merck & Co., Inc. Response to Todays New York Medicaid Suit
5. Mylan Vice Chairman and CEO Robert J. Coury to Ring NYSE Closing Bell(R) in Celebration of Merck Generics Acquisition
6. AHF Challenges Merck Over Steep Price of Its New AIDS Drug, Isentress
7. ImClone and Bristol-Myers Squibb Announce Joint Agreement With Merck KGaA to Co-Develop and Co-Commercialize ERBITUX(R) in Japan
8. Dynavax and Merck & Co., Inc. Announce Partnership to Develop HEPLISAV(TM), an Investigational Hepatitis B Vaccine Currently in Phase 3
9. The Lanier Law Firm Announces $4.85 Billion National Vioxx Settlement With Merck & Co. Inc.
10. GlaxoSmithKline Obtains Exclusive U.S. OTC Marketing Rights to MEVACOR(R) (lovastatin) from Merck & Co., Inc.
11. ICx Technologies Works With Merck & Co., Inc. to Develop Cancer Diagnostic Technology
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
 Merck KGaA and Nano-Terra Announce Extension of Nanotechnology Solutions Alliance 
(Date:5/27/2015)... “ Nursing Homes are starting to supplant ... title of a recent April 2015 New York Times article. ... to the hospital, 20-plus years of research have documented the ... high-quality nursing homes are both safer for older patients and ... nursing homes varying widely, patients and family members may worry ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 While hair ... hair loss, a new pilot study conducted by a ... Surgery (ISHRS) has found hair follicle grafting can help ... research was partially funded by ISHRS, which offers research ... to hair restoration. , In the past decade, ...
(Date:5/27/2015)... The new http://www.carsonenergy.com includes extensive oil ... oil and gas investing, the substantial tax benefits available ... news, IRA investing, definitions and acronyms, info-graphics and educational ... experience is now in one central location, for the ... access 24 hours a day, 7 days a week. ...
(Date:5/27/2015)... NJ (PRWEB) May 27, 2015 ... Network (BCAN) , whose mission is to advance research, ... cancer, have joined forces to battle the fifth most ... in the bladder’s lining start to grow out of ... and their families at every stage of the cancer ...
(Date:5/27/2015)... May 27, 2015 Difass USA, a ... the U.S. with its first three flagship products, Dormiva™, ... purchase nationwide through http://www.difassusa.com . , A ... and productivity, but some people struggle with getting the ... is a sleep aid designed to help you fall ...
Breaking Medicine News(10 mins):Health News:BestNursingHomes.com Launches on National Senior Health and Fitness Day 2Health News:New Research Finds Hair Grafting a Promising Therapy for Chronic Leg Ulcers - International Society of Hair Restoration Surgery Awards Research Grant 2Health News:New Research Finds Hair Grafting a Promising Therapy for Chronic Leg Ulcers - International Society of Hair Restoration Surgery Awards Research Grant 3Health News:Carson Energy Launches Next Generation Investor Website 2Health News:CURE® Magazine and Bladder Cancer Advocacy Network Align to Increase Awareness of Fifth Most Common Type of Cancer 2Health News:CURE® Magazine and Bladder Cancer Advocacy Network Align to Increase Awareness of Fifth Most Common Type of Cancer 3Health News:Supplement Brand Difass USA Launches in the U.S. with Three Flagship Products Designed to Bring Balance Back to Your Life 2
... 9 Quark Pharmaceuticals, Inc., a development-stage pharmaceutical ... therapeutics, today announced that Bruce A. Molitoris, M.D., ... Indiana University , will present data demonstrating ... disease (AKI and CKD, respectively) of an animal ...
... Prevention Departments are Under-financed, Under-staffed; Patient Safety Weakened , ... are cutting staff, resources and education for infection prevention ... infections is increasing, according to a report released today ... Epidemiology (APIC). , , The "2009 ...
... Rebuild After Physical Activity , , COLUMBUS, Ohio, June 9 ... (NYSE: ABT ) today announced the EAS(R) ... on the go refuel after physical activity. The ready-to-drink sports nutrition ... , , To view the Multimedia News Release, go to: ...
... and dental expand cost-effective solutions for today,s challenging economy ... BlueCross BlueShield (Empire) today announced approval by the New ... Disability insurance as part of their broad benefit portfolio. ... Disability Insurance Company, this addition makes Empire a leading ...
... brain may help you find solutions while asleep, study suggests ... need to solve a problem, sleep on it, researchers suggest. ... University of California, San Diego, researchers say that rapid ... forming new associative networks in the brain. , "We found ...
... June 9 Par Pharmaceutical Companies, Inc. (NYSE: ... spray to the trade. Calcitonin-salmon nasal spray is a ... sales of Miacalcin were approximately $112 million in 2008, according ... Important information about calcitonin-salmon nasal spray , , ...
Cached Medicine News:Health News:Quark Pharmaceuticals Announces the Presentation of Data Indicating Potential Utility of QPI-1002 in Chronic Kidney Disease at the RNA Interference Summit 2Health News:Quark Pharmaceuticals Announces the Presentation of Data Indicating Potential Utility of QPI-1002 in Chronic Kidney Disease at the RNA Interference Summit 3Health News:Quark Pharmaceuticals Announces the Presentation of Data Indicating Potential Utility of QPI-1002 in Chronic Kidney Disease at the RNA Interference Summit 4Health News:Hospital Infection Prevention Resources Cut, Study Says 2Health News:Hospital Infection Prevention Resources Cut, Study Says 3Health News:Abbott Announces New EAS(R) Myoplex(R) Strength Formula Nutrition Shake and Debuts Bottle Packaging 2Health News:Abbott Announces New EAS(R) Myoplex(R) Strength Formula Nutrition Shake and Debuts Bottle Packaging 3Health News:Abbott Announces New EAS(R) Myoplex(R) Strength Formula Nutrition Shake and Debuts Bottle Packaging 4Health News:Abbott Announces New EAS(R) Myoplex(R) Strength Formula Nutrition Shake and Debuts Bottle Packaging 5Health News:Empire BlueCross BlueShield Adds Life Insurance, Becomes Full-Service Benefits Provider 2Health News:Empire BlueCross BlueShield Adds Life Insurance, Becomes Full-Service Benefits Provider 3Health News:Empire BlueCross BlueShield Adds Life Insurance, Becomes Full-Service Benefits Provider 4Health News:Got a Problem? Think About It Overnight 2Health News:Par Pharmaceutical Begins Shipment of Generic Miacalcin(R) 2
(Date:5/27/2015)... -- With all the daily obstacles facing physicians these days, ... patients healthy should be easy. Unfortunately, it isn,t always. ... Act continues to affect the way physicians are reimbursed ... important than ever that medical practices have open and ... for patient care. Each year, cloud-based services ...
(Date:5/27/2015)... Tout voyageur ... Il nuit sérieusement à la productivité. Il ... réunions de mi-journée et vous empêche de ... dans votre chambre d,hôtel. Même une semaine ... de vous empêcher de tenir compagnie à ...
(Date:5/27/2015)... 2015 Research and Markets ... the "2015 Strategies in the European Coagulation ... This comprehensive five-country report contains 500 pages, ... suppliers and potential market entrants identify and evaluate ... market during the next five years. ...
Breaking Medicine Technology:Physicians Seek Payer Inclusion, Not Impediment 2Physicians Seek Payer Inclusion, Not Impediment 3HumanCharger, l'allié des sportifs d'élite, vous aide à vaincre le décalage horaire deux fois plus vite 2HumanCharger, l'allié des sportifs d'élite, vous aide à vaincre le décalage horaire deux fois plus vite 3HumanCharger, l'allié des sportifs d'élite, vous aide à vaincre le décalage horaire deux fois plus vite 4European Coagulation Testing Market Strategies 2015 2
Comfor™ Cast Boot - Rocker Sole - Closed Toe...
The Multi-Purpose Medical-Surgical Shoe...
... assay for the qualitative and ... to Gliadin in human serum. ... be used as an aid ... disorders, mainly Coeliac Disease. This ...
... use as a non-reactive quality assurance reagent in ... gondii (TOXO IgG and TOXO IgM), IgG and ... rubella IgM), IgG and IgM antibodies to cytomegalovirus ... antibodies to herpes simplex virus types 1 and ...
Medicine Products: